Table 1

Studies of the cost of congenital rubella syndrome
First author [Reference] de Owens [[15]] Robinson [[16]] Lanzieri [[14]] Al-Awaidy [[13]]
Country Panama Jamaica Brazil Oman
Year 1989 1998 2004 2006
WB income group Upper middle Upper middle Upper middle High
Perspective Health system* Health system* Health system Societal
Cost components measured NR NR Diagnosis; OP care; Hospitalization Surgery; 1st year of FU Diagnosis; OP care; Hospitalization Surgery; Drugs; Equipment; Special schools; Indirect costs
Method of cost estimation NR NR Micro-costing using reimbursement data Micro-costing using accounts data (treatment costs); Human capital approach (for indirect costs)
Time period for costing Annual Annual Annual (1st year) Lifetime
Discounting (Rate) NA NA NA Yes (3%)
Results (2012 US$) $58,023 $57,010 $4,261 $139,910
Sponsor NR NR NR Oman MOH*

*Not explicitly reported but inferred.

WB, World Bank; NR, Not Reported; NA, Not Applicable; OP, Out-Patient; FU, Follow-Up; CRS, Congenital Rubella Syndrome; MOH, Ministry of Health.

Babigumira et al.

Babigumira et al. BMC Public Health 2013 13:406   doi:10.1186/1471-2458-13-406

Open Data